# Dexamethasone in Total Knee Arthroplasty

> **NCT05018091** · PHASE4 · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 404 (actual)

## Conditions studied

- Total Knee Arthroplasty

## Interventions

- **DRUG:** Dexamethasone 4mg
- **DRUG:** Dexamethasone 8 Mg/mL Injectable Suspension
- **DRUG:** Dexamethasone 16mg

## Key facts

- **NCT ID:** NCT05018091
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-28
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-05-30
- **Target enrollment:** 404 (ACTUAL)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05018091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05018091, "Dexamethasone in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05018091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*